Det bemærkedes, at dosisreduktioner nedsatte eller standsede progressionen af miltforstørrelse, og hos 3% af patienterne opstod behov for
Dose reductions were noted to slow or stop the progression of splenic enlargement and in 3% of patients a splenectomy was required.